EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Relationship of Alzheimer’s Disease and Related Dementias Plasma Biomarkers With Mobility in Cognitively Unimpaired Older Adults

Atalie C Thompson iD, Xiaoyan Leng, Michael E Miller, Thomas C Register, Paul J Laurienti, Michelle M Mielke iD, Suzanne Craft, Stephen B Kritchevsky iD

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025

DOI: 10.1093/gerona/glaf110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Atalie C Thompson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Mobility Limitation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Wake Forest Claude D. Pepper Center, Wake Forest Clinical and Translational Science Awards.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Temporal relationships between physical and cognitive decline with aging are poorly understood, and little is known about the underlying mechanisms linking these conditions. We hypothesized that plasma biomarkers of Alzheimer’s disease and related dementias may be associated with mobility performance in older adults who are cognitively unimpaired.

Methods

We constructed separate linear mixed models to examine the cross-sectional associations of 5 plasma Alzheimer’s disease and related dementias and aging-related biomarkers with 4 measures of mobility in a cohort of 192 cognitively unimpaired older adults. We secondarily described the association of the same biomarkers with 4 cognitive domain scores.

Results

Higher phorphorylated-tau181 was associated with worse performance on the expanded short physical performance battery, slower 4 m gait speed, and shorter balance time. Higher neurofilament light was associated with worse expanded short physical performance battery, slower 4 m gait speed, and slower 400 m gait speed in adjusted models. However, there was no association of Aβ42/Aβ40, p-tau217, or glial fibrillary acidic protein with mobility. Only p-tau217 was associated with global and processing speed cognitive domain scores in multivariable models, but not after adjusting for multiple comparisons.

Conclusions

These data suggest that p-tau181 and neurofilament light are potential markers of mobility performance in cognitively normal older adults, even when they are not associated with cognitive performance. Future studies should examine how such markers predict change over time in mobility and cognitive function and whether they may indicate pathways that could be targeted for preventive management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMobility LimitationHumansMaleBiomarkersFemaleAgedCross-Sectional StudiesNeurofilament ProteinsAged, 80 and overAmyloid beta-Peptidestau ProteinsWalking SpeedCognition

Stichwörter der Autor:innen

Alzheimer’s diseaseFunctional performanceGait

Substanzen

BiomarkersNeurofilament ProteinsAmyloid beta-Peptidestau Proteinsneurofilament protein L

Autor:innen und Institutionen

  • Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Division of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
  • Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

ORCID-Profile: Atalie C Thompson, Michelle M Mielke, Stephen B Kritchevsky

Förderung

  • NIA NIH HHS
  • Wake Forest Claude D. Pepper Center
  • Wake Forest Clinical and Translational Science Awards
  • National Institute of Aging
  • NCATS NIH HHS
  • Wake Forest Alzheimer's Disease Research Center
  • Wake Forest Alzheimer’s Disease Research Center

Zitieren

APA

Thompson, A. C., Leng, X., Miller, M. E., Register, T. C., Laurienti, P. J., Mielke, M. M., Craft, S., & Kritchevsky, S. B. (2025). Relationship of Alzheimer’s Disease and Related Dementias Plasma Biomarkers With Mobility in Cognitively Unimpaired Older Adults. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf110

Vancouver

Thompson AC, Leng X, Miller ME, Register TC, Laurienti PJ, Mielke MM, et al. Relationship of Alzheimer’s Disease and Related Dementias Plasma Biomarkers With Mobility in Cognitively Unimpaired Older Adults. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf110

BibTeX
@article{Thompson2025,
  author = {Thompson, Atalie C and Leng, Xiaoyan and Miller, Michael E and Register, Thomas C and Laurienti, Paul J and Mielke, Michelle M and Craft, Suzanne and Kritchevsky, Stephen B},
  title = {Relationship of Alzheimer’s Disease and Related Dementias Plasma Biomarkers With Mobility in Cognitively Unimpaired Older Adults},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  doi = {10.1093/gerona/glaf110}
}
Kostenlos starten →